Fatemeh Ezzatifar

587 total citations
23 papers, 439 citations indexed

About

Fatemeh Ezzatifar is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Fatemeh Ezzatifar has authored 23 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Immunology and 4 papers in Oncology. Recurrent topics in Fatemeh Ezzatifar's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Immune Cell Function and Interaction (3 papers). Fatemeh Ezzatifar is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Immune Cell Function and Interaction (3 papers). Fatemeh Ezzatifar collaborates with scholars based in Iran, Russia and Belgium. Fatemeh Ezzatifar's co-authors include Jamshid Gholizadeh Navashenaq, Arezoo Gowhari Shabgah, Majid Ahmadi, Hamed Mohammadi, Sajad Najafi, Yahya Asemani, Seyed Mohammad Gheibihayat, Amirmorteza Ebrahimzadeh Namvar, Babak Asghari and Abdolaziz Rastegar Lari and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Pharmacology and Journal of Cellular and Molecular Medicine.

In The Last Decade

Fatemeh Ezzatifar

22 papers receiving 432 citations

Peers

Fatemeh Ezzatifar
Jacob Cardenas United States
Hyeon‐Gun Jee South Korea
Manasi P. Jogalekar United States
Jacob Cardenas United States
Fatemeh Ezzatifar
Citations per year, relative to Fatemeh Ezzatifar Fatemeh Ezzatifar (= 1×) peers Jacob Cardenas

Countries citing papers authored by Fatemeh Ezzatifar

Since Specialization
Citations

This map shows the geographic impact of Fatemeh Ezzatifar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatemeh Ezzatifar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatemeh Ezzatifar more than expected).

Fields of papers citing papers by Fatemeh Ezzatifar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatemeh Ezzatifar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatemeh Ezzatifar. The network helps show where Fatemeh Ezzatifar may publish in the future.

Co-authorship network of co-authors of Fatemeh Ezzatifar

This figure shows the co-authorship network connecting the top 25 collaborators of Fatemeh Ezzatifar. A scholar is included among the top collaborators of Fatemeh Ezzatifar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatemeh Ezzatifar. Fatemeh Ezzatifar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amiri, Somayeh, et al.. (2024). Beyond biomarkers: Exploring the diverse potential of a novel phosphoprotein in lung cancer management. Journal of Cellular and Molecular Medicine. 28(18). e70077–e70077.
2.
Ezzatifar, Fatemeh, et al.. (2023). Mesenchymal stromal cells and CAR‐T cells in regenerative medicine: The homing procedure and their effective parameters. European Journal Of Haematology. 112(2). 153–173. 10 indexed citations
3.
Ahmad, Saeed Nazari Soltan, et al.. (2022). TGF-β1 receptor blockade attenuates unilateral ureteral obstruction-induced renal fibrosis in C57BL/6 mice through attenuating Smad and MAPK pathways. Journal of Molecular Histology. 53(4). 691–698. 9 indexed citations
4.
5.
Ezzatifar, Fatemeh, Alireza Rafiei, & Mahmood Jeddi‐Tehrani. (2022). Nucleolin; A tumor associated antigen as a potential lung cancer biomarker. Pathology - Research and Practice. 240. 154160–154160. 8 indexed citations
6.
Ezzatifar, Fatemeh, Alireza Rafiei, Reza Valadan, Hossein Asgarian‐Omran, & Mahmood Jeddi‐Tehrani. (2022). Detection of Novel Autoantibodies to Nucleolin's RNA-binding Domains as a Serum Tumor Biomarker Through ELISA. Iranian Journal of Allergy Asthma and Immunology. 21(6). 616–625. 2 indexed citations
7.
Asemani, Yahya, Sajad Najafi, Fatemeh Ezzatifar, Naime Majidi Zolbanin, & Reza Jafari. (2022). Recent highlights in the immunomodulatory aspects of Treg cell-derived extracellular vesicles: special emphasis on autoimmune diseases and transplantation. Cell & Bioscience. 12(1). 67–67. 29 indexed citations
8.
Ezzatifar, Fatemeh, Shahram Torkamandi, Fatemeh Mohammadi, et al.. (2021). Association of the genetic variants in the endoplasmic reticulum aminopeptidase 2 gene with ankylosing spondylitis susceptibility. International Journal of Rheumatic Diseases. 24(4). 567–581. 1 indexed citations
9.
Shabgah, Arezoo Gowhari, Fatemeh Ezzatifar, A. Surendar, et al.. (2021). Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy. IUBMB Life. 73(4). 659–669. 44 indexed citations
10.
Mohammadi, Fatemeh, Fatemeh Ezzatifar, Armita Mahdavi Gorabi, et al.. (2021). Matrix metalloproteinases are involved in the development of neurological complications in patients with Coronavirus disease 2019. International Immunopharmacology. 100. 108076–108076. 31 indexed citations
11.
Rahmati, Yazdan, Yahya Asemani, Shahin Aghamiri, Fatemeh Ezzatifar, & Sajad Najafi. (2021). CiRS-7/CDR1as; An oncogenic circular RNA as a potential cancer biomarker. Pathology - Research and Practice. 227. 153639–153639. 36 indexed citations
12.
Shabgah, Arezoo Gowhari, Fatemeh Ezzatifar, Naseh Pahlavani, et al.. (2021). Curcumin and cancer; are long non-coding RNAs missing link?. Progress in Biophysics and Molecular Biology. 164. 63–71. 33 indexed citations
13.
Shabgah, Arezoo Gowhari, Maytham T. Qasim, Seyed Mojtaba Mostafavi, et al.. (2021). CXC chemokine ligand 16: a Swiss army knife chemokine in cancer. Expert Reviews in Molecular Medicine. 23. e4–e4. 26 indexed citations
14.
Shabgah, Arezoo Gowhari, Zahraa Haleem Al‐qaim, Alexander Markov, et al.. (2021). Chemokine CXCL14; a double-edged sword in cancer development. International Immunopharmacology. 97. 107681–107681. 46 indexed citations
15.
Shabgah, Arezoo Gowhari, Wanich Suksatan, Dmitry Olegovich Bokov, et al.. (2021). Arctigenin, an anti-tumor agent; a cutting-edge topic and up-to-the-minute approach in cancer treatment. European Journal of Pharmacology. 909. 174419–174419. 36 indexed citations
16.
Севбитов, А В, Fatemeh Ezzatifar, Maryam Hemmatzadeh, et al.. (2021). microRNAs: Small molecules with a large impact on colorectal cancer. Biotechnology and Applied Biochemistry. 69(5). 1893–1908. 11 indexed citations
17.
Mehrabian, Sedigheh, et al.. (2013). Silver nanoparticles as active ingredient used for alcohol-free mouthwash. SHILAP Revista de lepidopterología. 8(1). Doc05–Doc05. 18 indexed citations
18.
Aghebati‐Maleki, Leili, Behzad Baradaran, Jalal Abdolalizadeh, Fatemeh Ezzatifar, & Jafar Majidi. (2013). A Unique Report: Development of Super Anti-Human IgG Monoclone with Optical Density Over Than 3. SHILAP Revista de lepidopterología. 3(2). 333–7. 4 indexed citations
19.
Ezzatifar, Fatemeh, Jafar Majidi, Behzad Baradaran, et al.. (2013). Large Scale Generation and Characterization of Anti-Human CD34 Monoclonal Antibody in Ascetic Fluid of Balb/c Mice. SHILAP Revista de lepidopterología. 3(1). 211–102. 20 indexed citations
20.
Namvar, Amirmorteza Ebrahimzadeh, Babak Asghari, Fatemeh Ezzatifar, Gholamreza Azizi, & Abdolaziz Rastegar Lari. (2013). Detection of the intercellular adhesion gene cluster (ica) in clinical Staphylococcus aureus isolates. SHILAP Revista de lepidopterología. 8(1). Doc03–Doc03. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026